Skip to main content
. 2018 Jul 27;9(58):31173–31186. doi: 10.18632/oncotarget.25168

Table 1. Demographic and clinical characteristics of the participants.

Characteristics Overall P-value
Sex Men (%) 48.2% <0.001
Women (%) 51.8%
Age (Years) 47.2 ± 1.3
Race/Ethnicity White (non-Hispanic) (%) 69.3% <0.001
Non-Hispanic Black (%) 11.9%
Mexican-American (%) 8.0%
Other Hispanic (%) 4.4%
Other (%) 6.3%
Marital Status Married (%) 55.9% <0.001
Widowed (%) 16.9%
Divorced (%) 10.9%
Never married (%) 17.8%
Body mass index (kg/m2) 28.1 ± 0.02
Waist circumference (cm) 97.2 ± 0.29
Anthropometrically Predicted Visceral Adipose Tissue 165.9 ± 2.36
TyG index 7.92 ± 0.01
TG:HDL ratio 3.5 ± 0.03
Serum CRP (mg/dL) 0.49 ± 0.02
Serum apolipoprotein B (mg/dL) 34.9 ± 0.82
Fasting blood glucose (mg/dL) 101.4 ± 1.26
Plasma insulin (uU/mL) 2.34 ± 0.02
HOMA-IR 0.86 ± 0.03
HOMA-B 4.72 ± 0.04
HbA1c (%) 5.42 ± 0.09
2 h Blood Glucose (mg/dL) 119.3 ± 1.26
Visceral Adiposity Index 2.4 ± 0.001
Lipid accumulation product 66.3 ± 0.93

Abbreviations: HOMA-IR: Homeostatic model assessment of insulin resistance; HOMA-B: Homeostatic model assessment of β-cell function, HbA1c: glycated haemoglobin A1c, TyG index: triglyceride-glucose index, HDL: high-density lipoprotein, CRP:C-reactive protein.

Values are expressed as estimated mean and standard error or percent.